“ECU and VMC are leading in the use of this technology because we have an aggressive multidisciplinary approach to lung cancer,” said Dr. Mark Bowling, director of interventional pulmonology. #VidantMedicalCenter #VidantCancerCare Learn more about the study, including a link to the abstract of the research article: